Singapore-MIT Research Alliance Developing Sample Prep, Dx Method for Low-Abundance Microorganisms
Researchers from the Singapore-MIT Alliance for Research and Technology has adapted a novel electrostatic microfilter to enhance detection of low concentrations of pathogens.
With $8 million in seed funding, Droplet is developing a test for minimal residual disease detection in head and neck cancer, with research ongoing for other promising targets.
The paper-based assay detects the presence of neutralizing antibodies in the blood and can return results in 10 minutes.
The electrochemical test detects both the presence of SARS-CoV-2 RNA as well as virus antibodies in saliva.
Aiming to increase test performance, the developers are integrating separate sensors to detect protein and nucleic acid biomarkers for SARS-CoV-2 in a single platform.